mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?
Published in Nephrology Dialysis Transplantation, 2022
This publication is available via DOI.
Recommended citation: Wijtvliet, V.P.W.M., Ariën, K.K., Abrams, S., Couttenye, M.M., Mestrez, F., Mariën, J., De Winter, B.Y., Van Damme, P., Pipeleers, L., Wissing, K.M., Abramowicz, D., & Ledeganck, K.J. (2022) "mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?." Nephrology Dialysis Transplantation. 37(4), 799–803.